GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Polaris Group (TPE:6550) » Definitions » Other Financing

Polaris Group (TPE:6550) Other Financing : NT$0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Polaris Group Other Financing?

Polaris Group's Other Financing for the three months ended in Sep. 2024 was NT$0.00 Mil.

Polaris Group's Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 was NT$0.00 Mil.

Polaris Group Other Financing Historical Data

The historical data trend for Polaris Group's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris Group Other Financing Chart

Polaris Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Polaris Group Quarterly Data
Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Polaris Group Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polaris Group Other Financing Related Terms

Thank you for viewing the detailed overview of Polaris Group's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Polaris Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Polaris Group (TPE:6550) » Definitions » Other Financing
Comparable Companies
ROCO:6589 ROCO:4743 ROCO:6547 ROCO:6919 ROCO:4147 ROCO:6617 ROCO:4174 ROCO:6976 ROCO:4162 ROCO:6712 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
NO.298, Ruiguang Road, 7th floor, Neihu District, Taipei, TWN
Website
https://www.polarispharma.com
Polaris Group is a multinational biotechnology company focused on developing novel anti-cancer therapies. The company's lead therapeutic Pegargiminase (ADI PEG 20), is a biologic in late-stage clinical development for a wide range of cancers, including hepatocellular carcinoma, mesothelioma, pancreatic cancer, non-small cell lung cancer, melanoma, acute myeloid leukemia and others. Polaris Group is also involved in every stage of the drug development process.

Polaris Group Headlines

No Headlines